Cargando…
Preliminary clinical study of the safety of hepatectomy predicted by gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced T1 mapping magnetic resonance imaging
BACKGROUND AND AIM: Studies have found that gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid (Gd‐EOB‐DTPA)‐enhanced T1 mapping magnetic resonance imaging (MRI) could assess liver fibrosis, cirrhosis, and function with high effectiveness. The aim of this study is to explore the efficacy of...
Autores principales: | Liu, Jiao, Li, Qingtao, Shi, Nannan, Chen, Yi, Li, Yesheng, Zhang, Meng, Huang, Yangqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936624/ https://www.ncbi.nlm.nih.gov/pubmed/33732886 http://dx.doi.org/10.1002/jgh3.12507 |
Ejemplares similares
-
Consensus Report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging
por: Lee, Jeong Min, et al.
Publicado: (2011) -
Hepatocellular carcinoma grading and recurrence prediction using T(1) mapping on gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging
por: Qin, Xiali, et al.
Publicado: (2019) -
Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery
por: Shimada, Shingo, et al.
Publicado: (2020) -
Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase
por: Hayashi, Manabu, et al.
Publicado: (2018) -
Imaging of Biliary Involvement in Sarcoidosis: Computed Tomography, Magnetic Resonance Cholangiopancreatography, and Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging Findings
por: Renzulli, Matteo, et al.
Publicado: (2021)